The market for surgical knee cartilage repair is large and growing; over 650 000 surgeries are performed in the US annually and the global market is also rapidly evolving. We believe we have a product that fits this global need, and therefore we aim to become the global standard for surgical cartilage repair. We can serve this market with our propriety and industrially scalable in-house production capability. (2)
We are applying for funding for clinical validation and market authorizations in the EU and the US.
Product development in the medical field is time and resource consuming, controlled by the authorities and involves significant risks. Turnover only begins to accumulate after the product has been subjected to the necessary tests to demonstrate compliance with the requirements and has received regulatory approval.
1 Aiyong, C., Huizi, L., Dawei, W., Junlong, Z., Yufeng, C., Huading, L. (2022). Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. The Lancet Discovery Science, Volume 29, 100587.
2 Mosley, J., et al. (2002). A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee. N Engl J Med 2002; 347:81-88.